| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/26/2010 | US20100216186 Novel sesquiterpene synthase gene and protein |
| 08/26/2010 | US20100216185 Engineered versions of polysialyltransferases with enhanced enzymatic properties |
| 08/26/2010 | US20100216184 Preparation of cell extract and its application for cell-free protein systhesis |
| 08/26/2010 | US20100216140 Novel Human Dickkopf-Related Protein and Nucleic Acid Molecules and uses Therefor |
| 08/26/2010 | US20100215693 Immunological herpes simplex virus antigens and methods for use thereof |
| 08/26/2010 | US20100215669 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 08/26/2010 | US20100215666 Il-17 antagonistic antibodies |
| 08/26/2010 | US20100215664 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6 -mediated signalling |
| 08/26/2010 | US20100215651 Humanized antibodies that bind to CD19 and their uses |
| 08/26/2010 | US20100215572 Methods of treatment using ldcam |
| 08/26/2010 | CA2753280A1 Anti-human .alpha.9 integrin antibody and use thereof |
| 08/26/2010 | CA2753075A1 Fermentation broth formulations |
| 08/25/2010 | EP2221384A1 Method for production of antibody |
| 08/25/2010 | EP2221374A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 08/25/2010 | EP2221371A1 Translation regulation system in cell or artificial cell model by using low-molecular-weight rna |
| 08/25/2010 | EP2221370A1 Process for production of non-natural protein having ester bond therein |
| 08/25/2010 | EP2221367A1 Protein-responsive translation control system utilizing rna-protein interaction motif |
| 08/25/2010 | EP2221366A1 Polypeptides having alpha-glucosidase activity and polynucleotides encoding same |
| 08/25/2010 | EP2221361A2 Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium |
| 08/25/2010 | EP2221316A1 Anti-CD19 antibody therapy for autoimmune disease |
| 08/25/2010 | EP2221311A1 Novel nucleic acid base pair |
| 08/25/2010 | EP2220246A1 Methods of processing recombinant procollagen |
| 08/25/2010 | EP2220245A1 Method and composition for crystallizing g protein-coupled receptors |
| 08/25/2010 | EP2220218A2 A genetically encoded boronate amino acid |
| 08/25/2010 | EP2220105A2 Production of high mannose proteins in plant culture |
| 08/25/2010 | EP2219671A1 Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors |
| 08/25/2010 | EP1075513B1 Continuous in vitro evolution |
| 08/25/2010 | CN101812496A Preparation method for high purity fish scale collagen |
| 08/25/2010 | CN101812495A Process for preparing casein phosphopeptide |
| 08/25/2010 | CN101812474A Preparation method and application of osteoporotegerin-heat-shock protein 65-fused protein |
| 08/25/2010 | CN101812414A Lactobacillus plantarum and bacteriocins produced by lactobacillus plantarum and capable of inhibiting Gram negative bacteria |
| 08/25/2010 | CN101812117A Method for extracting glutathione |
| 08/25/2010 | CN101812116A Giant salamander oligosaccharide peptide, preparation method and application thereof in cosmetics |
| 08/25/2010 | CN101353641B Method for improving RTN4B protein yield |
| 08/25/2010 | CN101195655B Regulating protein for polyoxin synthesis, encoding gene and application thereof |
| 08/25/2010 | CN101096696B Industrial production method of corn protein polypeptide from corn protein powder by enzymatical process |
| 08/24/2010 | USRE41555 Antibody purification |
| 08/24/2010 | US7781574 chimeric nucleic acid sequence encoding a polypeptide comprising a nuclear localization signal of a viral protein and a fragment of an osteogenic factor having osteogenic activity; for treating disc disease associated with trauma or disc degeneration |
| 08/24/2010 | US7781397 Immunoaffinity purification |
| 08/24/2010 | US7781210 Natural killer cell line for use as tool in elucidation of mechanism of oncogenesis; identifying modulator for treatment of cell proliferative disorders |
| 08/24/2010 | US7781209 overexpress G protein coupled receptor (GPCR) proteins; used to identify a test compound which modulates the activity of the GPCR protein; drug screening; stable, high-expression systems capable of providing multiple copies of GPCR proteins |
| 08/24/2010 | US7781201 have increased activity and stability at acidic, neutral and alkaline pH and increased temperature; for producing an alcohol, high-maltose or high-glucose syrup or a mixed syrup, and for liquifying a starch-comprising composition |
| 08/24/2010 | US7781200 Polypeptides having lipase activity and polynucleotides encoding same |
| 08/24/2010 | US7781198 Nucleotide sequences coding enzymatic polypeptide for use as amplification tool in genetic engineering |
| 08/24/2010 | US7781197 Transformed bryophyte cell having disrupted endogenous alpha 1,3-fucosyl and beta 1,2-xylosyl transferase encoding nucleotide sequences for the production of heterologous glycosylated proteins |
| 08/24/2010 | US7781196 mutant protein of PQQ-dependent s-GDH (glucose dehydrogenase) with the A. calcoaceticus s-GDH wild-type sequence; for measurement of glucose, especially by a tests strip device or with a biosensor |
| 08/24/2010 | US7781192 Method for producing D-pantothenic acid and/or a salt thereof via purification by cation exchange as additive for animal food |
| 08/24/2010 | US7781188 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 08/24/2010 | US7781158 Isolating connective tissue protein from porcine bone tissue via pepsin digestion, salt fractionation and ethanol extraction |
| 08/24/2010 | US7780959 Feline granulocyte macrophage colony stimulating factor nucleic acid molecules |
| 08/24/2010 | US7780946 Supported catalyst systems |
| 08/24/2010 | CA2512442C Method for producing .alpha.-l-aspartyl-l-phenylalanine-.beta.-ester and method for producing .alpha.-l-aspartyl-l-phenylalanine-.alpha.-methyl ester |
| 08/24/2010 | CA2507749C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 08/24/2010 | CA2438118C Plasmid shuttle vector between escherichia coli and bacteria of genus brevibacillus |
| 08/24/2010 | CA2431639C Using viruses to detect or purify proteins |
| 08/24/2010 | CA2356189C Substance for obtaining highly effective tumor medications as well as a process |
| 08/24/2010 | CA2181924C Diagnosis and treatment of infections due to streptococci and enterococci |
| 08/19/2010 | WO2010094011A1 Compositions and methods for improved livestock and aquaculture performance |
| 08/19/2010 | WO2010093480A2 Humanized anti-cd20 antibodies and methods of use |
| 08/19/2010 | WO2010093395A1 Immunoconjugates with an intracellularly-cleavable linkage |
| 08/19/2010 | WO2010093335A1 Antibodies for diagnosis and treatment of flaviviral infections |
| 08/19/2010 | WO2010092792A1 Method for removing phorbol ester from organic material, method for producing organic material having high protein content, organic material having high protein content, method for producing feed, and feed |
| 08/19/2010 | WO2010092778A1 Acid-soluble soybean protein material, and process for producing same |
| 08/19/2010 | WO2010092335A1 Method for producing protein |
| 08/19/2010 | WO2010075529A3 Heterologous biomass degrading enzyme expression in thermoanaerobacterium saccharolyticum |
| 08/19/2010 | US20100212033 Novel ubiquitin lifases as therapeutic tragets |
| 08/19/2010 | US20100212030 Use of n-terminal and c-terminal proteomics technology to enhance protein therapeutics and diagnostics |
| 08/19/2010 | US20100211015 Composition comprising hyaluronidase glycoprotein that is active at neutral pH and contains at least one sugar moiety that is covalently attached to an asparagine for use in treatment of diabetic disorders |
| 08/19/2010 | US20100210830 System for inducible expression in eukaryotic cells |
| 08/19/2010 | US20100210827 Preparation Method Of Recombinant Protein By Use Of A Fusion Expression Partner |
| 08/19/2010 | US20100210823 Method of Preparing Enriched Antibodies for Detecting Mycobacterial Infection |
| 08/19/2010 | US20100210815 Insulin production methods and pro-insulin constructs |
| 08/19/2010 | US20100210530 Extracellular matrix compositions |
| 08/19/2010 | US20100210508 Method for the Massive Culture of Cells Producing Recombinant Human Erythropoietin |
| 08/19/2010 | US20100210039 Sandwich immunoassay and monoclonal antibodies for comp, cartillage oligomeric matrix protein |
| 08/19/2010 | US20100209969 Geraniol synthase, methods of production and uses thereof |
| 08/19/2010 | US20100209968 Immobilized enzymes and uses thereof |
| 08/19/2010 | US20100209936 Novel recombinant 15-kDa polypeptide and use of same in detecting human infection with Bartonella henselae |
| 08/19/2010 | US20100209905 Protein d - an igd-binding protein of haemophilus influenzae |
| 08/19/2010 | US20100209445 Mutant double cyclized receptor peptides inhibiting beta1-adrenoceptor antibodies |
| 08/19/2010 | US20100209435 Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors |
| 08/19/2010 | US20100209425 Blood-Brain Barrier Targeting Anti-bodies |
| 08/19/2010 | US20100209422 Antibodies specific for the protofibril form of beta-amyloid protein |
| 08/19/2010 | US20100209346 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
| 08/19/2010 | US20100209342 Apcdd1 inhibitors for treating, diagnosing or detecting cancer |
| 08/19/2010 | US20100205754 Multi-Copper Oxidase CueO with Dyeability |
| 08/19/2010 | CA2750281A1 Method for removing phorbol ester in organic substance, method for producing high-protein organic substance, high-protein organic substance, method for producing feed and feed |
| 08/18/2010 | EP2218783A1 Novel method for the manufacturing of neurotoxins |
| 08/18/2010 | EP2218779A1 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof |
| 08/18/2010 | EP2218775A1 Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium |
| 08/18/2010 | EP2218733A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 08/18/2010 | EP2218732A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 08/18/2010 | EP2218731A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 08/18/2010 | EP2218730A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 08/18/2010 | EP2217716A2 Use of tam receptor inhibitors as antimicrobials |
| 08/18/2010 | EP2217702A2 Directed evolution using proteins comprising unnatural amino acids |
| 08/18/2010 | EP1625219B1 Methods for producing secreted polypeptides |
| 08/18/2010 | EP1461360B1 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 08/18/2010 | EP0723402B1 Senescent cell-derived inhibitors of dna synthesis |
| 08/18/2010 | CN101809162A anti-glypican-3 antibody having improved kinetics in plasma |